Literature DB >> 17845545

Fulminant liver failure secondary to haemorrhagic dengue in an international traveller.

James Gasperino1, Jose Yunen, Alice Guh, Kathryn E Tanaka, Vladimir Kvetan, Howard Doyle.   

Abstract

Dengue infections are caused by a single-stranded RNA virus, which has four serotypes (DEN 1-4); mosquitoes of the genus Aedes serve as vectors of transmission. Risk factors for dengue infection are related to both the host and virus. Age, gender, immune status, and genetic background of the host all contribute to the severity of dengue infection. Recently, international travel to endemic areas has also been identified as a major risk factor for both primary and secondary dengue infection. Dengue remains a diagnostic challenge, given its protean nature, ranging from mild febrile illness to profound shock. The most severe manifestation of dengue infection is dengue shock syndrome, which has an estimated mortality rate close to 50%. Dengue shock syndrome typically presents with increased anion gap metabolic acidosis, disseminated intravascular coagulation, severe hypotension, and jaundice. Liver involvement appears to occur more frequently when infections involve DEN-3 and DEN-4 serotypes. While hepatocellular damage has been reported previously in dengue infection, acute liver failure is an extremely rare occurrence in adults. We report a patient with dengue shock syndrome who presented with acute liver failure and hepatic encephalopathy after recent travel to an endemic area.

Entities:  

Mesh:

Year:  2007        PMID: 17845545     DOI: 10.1111/j.1478-3231.2007.01543.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  13 in total

Review 1.  Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.

Authors:  Rashedul Islam; Mohammed Salahuddin; Md Salahuddin Ayubi; Tahmina Hossain; Apurba Majumder; Andrew W Taylor-Robinson; Abdullah Mahmud-Al-Rafat
Journal:  Virol Sin       Date:  2015-10-20       Impact factor: 4.327

2.  Dengue--how best to classify it.

Authors:  Anon Srikiatkhachorn; Alan L Rothman; Robert V Gibbons; Nopporn Sittisombut; Prida Malasit; Francis A Ennis; Suchitra Nimmannitya; Siripen Kalayanarooj
Journal:  Clin Infect Dis       Date:  2011-08-10       Impact factor: 9.079

Review 3.  Beyond thrombocytopaenia, haemorrhage and shock: the expanded dengue syndrome.

Authors:  Senaka Rajapakse; Milanka Wattegama; Praveen Weeratunga; P Chathurani Sigera; Sumadhya Deepika Fernando
Journal:  Pathog Glob Health       Date:  2018-12-03       Impact factor: 2.894

4.  Incidence and Clinical Outcome of Acute Liver Failure Caused by Dengue in a Hospital for Tropical Diseases, Thailand.

Authors:  Khin Kye Mon; Apichart Nontprasert; Chatporn Kittitrakul; Pisit Tangkijvanich; Wattana Leowattana; Kittiyod Poovorawan
Journal:  Am J Trop Med Hyg       Date:  2016-10-17       Impact factor: 2.345

Review 5.  Dengue and its effects on liver.

Authors:  Jayanta Samanta; Vishal Sharma
Journal:  World J Clin Cases       Date:  2015-02-16       Impact factor: 1.337

6.  Successful use of N-acetyl cysteine and activated recombinant factor VII in fulminant hepatic failure and massive bleeding secondary to dengue hemorrhagic fever.

Authors:  Edirisooriya Maddumage Manoj; Gayan Ranasinghe; M K Ragunathan
Journal:  J Emerg Trauma Shock       Date:  2014-10

Review 7.  Dengue virus pathogenesis: an integrated view.

Authors:  Byron E E Martina; Penelope Koraka; Albert D M E Osterhaus
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

8.  Acute hepatic failure due to dengue: A case report.

Authors:  Subhash Giri; Mukul P Agarwal; Vishal Sharma; Ankur Singh
Journal:  Cases J       Date:  2008-10-02

Review 9.  Liver in systemic disease.

Authors:  Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

10.  The incubation periods of Dengue viruses.

Authors:  Miranda Chan; Michael A Johansson
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.